Sell 11/4/2024Upgraded
Metagenomi, Inc. (MGX) was upgraded to E+ from E on 11/4/2024 due to an increase in the growth index, volatility index and valuation index. Total revenue increased 79.3% from $11.16M to $20.01M, earnings per share increased from -$1.1897 to -$0.2932, and EBIT increased 41.92% from -$29.03M to -$16.86M.

Sell 8/1/2024Upgraded
Metagenomi, Inc. (MGX) was upgraded to E from E- on 8/1/2024 due to a significant increase in the solvency index, efficiency index and growth index. Earnings per share increased from -$5.6691 to -$1.1897, total capital increased 22.89% from $263.4M to $323.7M, and the quick ratio increased from 3.99 to 4.68.

Sell 5/7/2024None
Metagenomi, Inc. (MGX) was downgraded to E- from U on 05/07/2024.